Prati
Keunsoo Kang
Keunsoo Kang
Potvrđena adresa e-pošte na dankook.ac.kr - Početna stranica
Naslov
Citirano
Citirano
Godina
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
BR Beck, B Shin, Y Choi, S Park, K Kang
Computational and structural biotechnology journal 18, 784-790, 2020
8962020
Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation
SH Park, K Kang, E Giannopoulou, Y Qiao, K Kang, G Kim, KH Park-Min, ...
Nature immunology 18 (10), 1104-1116, 2017
2482017
AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2
H Kim, K Kang, J Kim
Nucleic acids research 37 (9), 2940-2950, 2009
2362009
Interferon-γ represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF
K Kang, SH Park, J Chen, Y Qiao, E Giannopoulou, K Berg, A Hanidu, J Li, ...
Immunity 47 (2), 235-250. e4, 2017
1952017
Self-attention based molecule representation for predicting drug-target interaction
B Shin, S Park, K Kang, JC Ho
Machine learning for healthcare conference, 230-248, 2019
1942019
A basal-like breast cancer-specific role for SRF–IL6 in YAP-induced cancer stemness
T Kim, SJ Yang, D Hwang, J Song, M Kim, S Kyum Kim, K Kang, J Ahn, ...
Nature communications 6 (1), 10186, 2015
1722015
The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer
S Yu, T Kim, KH Yoo, K Kang
Biochemical and Biophysical Research Communications 486 (3), 752-758, 2017
1422017
Human histone H3K79 methyltransferase DOT1L methyltransferase binds actively transcribing RNA polymerase II to regulate gene expression
SK Kim, I Jung, H Lee, K Kang, M Kim, K Jeong, CS Kwon, YM Han, ...
Journal of Biological Chemistry 287 (47), 39698-39709, 2012
1162012
IFN-γ selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation
K Kang, M Bachu, SH Park, K Kang, S Bae, KH Park-Min, LB Ivashkiv
Nature communications 10 (1), 3320, 2019
1082019
Barrier to autointegration factor 1, procollagen‐lysine, 2‐oxoglutarate 5‐dioxygenase 3, and splicing factor 3b subunit 4 as early‐stage cancer decision markers and drivers of …
Q Shen, JW Eun, K Lee, HS Kim, HD Yang, SY Kim, EK Lee, T Kim, ...
Hepatology 67 (4), 1360-1377, 2018
1012018
Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration
D Yamaji, K Kang, GW Robinson, L Hennighausen
Nucleic acids research 41 (3), 1622-1636, 2013
892013
MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas
JS Kim, EJ Kim, S Lee, X Tan, X Liu, S Park, K Kang, JS Yoon, YH Ko, ...
Experimental & molecular medicine 51 (1), 1-10, 2019
872019
Hrp3 controls nucleosome positioning to suppress non‐coding transcription in eu‐and heterochromatin
YS Shim, Y Choi, K Kang, K Cho, S Oh, J Lee, SIS Grewal, D Lee
The EMBO journal 31 (23), 4375-4387, 2012
782012
Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules
K Kang, GW Robinson, L Hennighausen
BMC genomics 14, 1-11, 2013
762013
QKI, a miR‐200 target gene, suppresses epithelial‐to‐mesenchymal transition and tumor growth
EJ Kim, JS Kim, S Lee, H Lee, JS Yoon, JH Hong, SH Chun, DS Sun, ...
International journal of cancer 145 (6), 1585-1595, 2019
752019
Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth
K Weidenfeld, S Schif-Zuck, H Abu-Tayeh, K Kang, O Kessler, ...
Oncotarget 7 (44), 71362, 2016
742016
α1‐3/4 fucosylation at Asn 241 of β‐haptoglobin is a novel marker for colon cancer: A combinatorial approach for development of glycan biomarkers
SY Park, SH Lee, N Kawasaki, S Itoh, K Kang, S Hee Ryu, N Hashii, ...
International Journal of Cancer 130 (10), 2366-2376, 2012
692012
Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC)
SY Kim, YK Han, JM Song, CH Lee, K Kang, JM Yi, HR Park
Clinical Epigenetics 11, 1-12, 2019
632019
Chromatin remodeller Fun30Fft3 induces nucleosome disassembly to facilitate RNA polymerase II elongation
J Lee, E Shik Choi, H David Seo, K Kang, JM Gilmore, L Florens, ...
Nature communications 8 (1), 14527, 2017
612017
Octopus-toolkit: a workflow to automate mining of public epigenomic and transcriptomic next-generation sequencing data
T Kim, HD Seo, L Hennighausen, D Lee, K Kang
Nucleic acids research 46 (9), e53-e53, 2018
592018
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20